Previous studies have shown that both serum and cerebrospinal fluid levels of CXCL13 are elevated in NMOSD patients compared with those with multiple sclerosis and healthy controls (6, 27–29), potentially promoting neuroinflammation by recruiting antibody-secreting B cells. This evidence concerns the gene CXCL13 and multiple sclerosis.